Free Trial
TSE:HLS

HLS Therapeutics (HLS) Stock Price, News & Analysis

HLS Therapeutics logo
C$3.99 -0.05 (-1.24%)
As of 03/10/2025 03:10 PM Eastern

About HLS Therapeutics Stock (TSE:HLS)

Key Stats

Today's Range
C$3.97
C$4.02
50-Day Range
C$3.77
C$4.26
52-Week Range
C$3.00
C$5.48
Volume
14,055 shs
Average Volume
16,539 shs
Market Capitalization
C$88.77 million
P/E Ratio
N/A
Dividend Yield
5.01%
Price Target
C$4.13
Consensus Rating
N/A

Company Overview

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States and the Rest of the world.

Remove Ads
Receive HLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HLS Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

HLS Stock News Headlines

Top Canadian Pharmaceutical Stocks of 2025
Optimistic Buy Rating for HLS Therapeutics Despite Revenue Challenges
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.
See More Headlines

HLS Stock Analysis - Frequently Asked Questions

HLS Therapeutics' stock was trading at C$3.93 at the beginning of 2025. Since then, HLS stock has increased by 1.5% and is now trading at C$3.99.
View the best growth stocks for 2025 here
.

HLS Therapeutics Inc. (TSE:HLS) released its earnings results on Thursday, November, 7th. The company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.19) by $0.01. HLS Therapeutics had a negative net margin of 38.70% and a negative trailing twelve-month return on equity of 25.27%.

Shares of HLS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that HLS Therapeutics investors own include Toronto-Dominion Bank (TD), Meta Platforms (META), NVIDIA (NVDA), CohBar (CWBR), Alphabet (GOOG), Great-West Lifeco (GWO) and ObsEva (OBSV).

Company Calendar

Last Earnings
11/07/2024
Today
3/10/2025

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
TSE:HLS
CIK
N/A
Fax
N/A
Employees
91
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$4.13
High Stock Price Target
C$5.00
Low Stock Price Target
C$3.25
Potential Upside/Downside
+3.4%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-15,528,530.76
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$40.13 million
Cash Flow
C$0.26 per share
Price / Cash Flow
15.22
Book Value
C$2.51 per share
Price / Book
1.59

Miscellaneous

Free Float
N/A
Market Cap
C$88.77 million
Optionable
Not Optionable
Beta
1.07
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (TSE:HLS) was last updated on 3/11/2025 by MarketBeat.com Staff
From Our Partners